Video walkthrough

Biotransformation and bioaccessibility of active ingredients from Radix Astragali by Poria cocos during solid-state fermentation and in vitro digestion and antioxidant activity evaluation

Student 6:01 CC AI

paperi.ai
0:00 / 0:00
Made with Paperi.

Drop in a research PDF — get a narrated video walkthrough like this one, with highlights that follow the narration. Free to start.

Try it with your paper →
Transcript

What if a simple fungus could turn a common herbal root into a supercharged health supplement? This study reveals how fermenting Radix Astragali with Poria cocos boosts its key active ingredient by over five times. Radix Astragali is a famous herbal medicine, but its main functional compound, Astragaloside IV, exists in very low amounts, limiting its use.

The researchers aimed to solve this by using Poria cocos to ferment the herb, hoping to improve both the transformation of the compound and its ability to be absorbed during digestion. Poria cocos is an edible and medicinal fungus known for immune-boosting effects, which makes it a perfect candidate to break down plant cell walls and release hidden nutrients.

During fermentation, this fungus uses cellulose as food to degrade the plant's cell wall, effectively helping to release the bioactive compounds trapped inside. Figure 1 tracks the dry weight of *Poria cocos* mycelium over a ten-day period to establish its growth kinetics.

The authors identify a rapid logarithmic phase from day two to day six, where mass accumulation accelerates significantly before peaking on the seventh day. Beyond this peak, the culture enters a senescence phase characterized by declining biomass.

This timeline is critical because it helps researchers correlate specific fungal growth stages with the biotransformation of active ingredients in the fermented extract. To find the ideal conditions, the authors tested different inoculation amounts, discovering that eight milliliters produced the highest levels of genistein and Astragaloside IV.

They concluded that eight milliliters was the optimal amount because increasing it further caused the beneficial compounds to decrease. Next, they varied the fermentation time, observing that the content of Astragaloside IV rose and then fell, reaching its maximum on the tenth day.

Because the mass accumulation of the target compound peaked at ten days, this duration was selected as the optimal fermentation time. Humidity also played a critical role; the team found that ninety percent humidity yielded the highest concentration of Astragaloside IV at nearly two thousand micrograms per gram.

Too much water created a sticky environment with poor oxygen flow, hindering fungal growth, so ninety percent was chosen as the optimal humidity. Under these optimized conditions, the content of Astragaloside IV skyrocketed from roughly three hundred eighty-five to nearly two thousand micrograms per gram.

This represents a massive five point sixteen-fold increase compared to the non-fermented control sample. Table 4 tracks the concentration of specific bioactive compounds across four distinct in vitro digestion stages, comparing a control sample against one that underwent fermentation.

The data reveals how levels of components like calycosin and genistin shift from the oral phase through to the final enteric phase II. Finally, the table quantifies the percentage of these compounds remaining as bioaccessible, providing a direct measure of their potential absorption after simulated digestion.

When calculating bioaccessibility, the fermented material showed much higher percentages for key compounds like total saponins and flavonoids compared to the control. This suggests that the enzymes produced by the fungus broke down cell walls and converted complex glucosides into more absorbable forms.

Figure 2 presents scanning electron micrographs comparing the surface structure of Radix Astragali before and after fermentation, as well as following simulated gastric and enteric digestion. The authors use these images to reveal that while the control sample starts with a smooth surface, the fermented sample exhibits a porous network even before digestion begins.

Furthermore, the visual evidence shows that both samples suffer severe structural damage under acidic conditions, but the fermented material appears more extensively destroyed than the control. Figure 3 plots the DPPH radical scavenging rates for various Radix Astragali samples and standards against their concentration.

The authors use this assay to compare antioxidant capacity, showing that Vitamin C achieves a rate of ninety-eight point two-five percent at zero point four milligrams per milliliter. In contrast, the fermented extract FRA reaches sixty-three point eight-one percent at that same concentration, while the non-fermented control sits lower at fifty-one point four-three percent.

Figure 4 plots the ABTS radical scavenging rates for various samples of Radix Astragali, standards, and Vitamin C across a concentration range from zero to point three milligrams per milliliter. The graph illustrates that as mass concentration increases, the antioxidant capacity generally rises, with the fermented sample FRA showing a steep increase compared to the control group.

This data supports the authors' conclusion that solid fermentation significantly enhances the bioactivity of the extract relative to untreated material. In conclusion, the study proves that fermenting Radix Astragali with Poria cocos is a highly effective method to boost active ingredients and antioxidant capacity.

This approach provides a solid scientific basis for developing new, more potent products from this traditional herbal medicine. Solid-state fermentation with Poria cocos dramatically increases the content and bioavailability of Astragaloside IV in Radix Astragali while enhancing its antioxidant power, offering a new path for herbal medicine development.